- Home
- RIOT vs APLS Comparison
RIOT vs APLS Comparison
Compare RIOT & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIOT
- APLS
- Stock Information
- Founded
- RIOT 2000
- APLS 2009
- Country
- RIOT United States
- APLS United States
- Employees
- RIOT N/A
- APLS N/A
- Industry
- RIOT Retail: Computer Software & Peripheral Equipment
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- RIOT Technology
- APLS Health Care
- Exchange
- RIOT Nasdaq
- APLS Nasdaq
- Market Cap
- RIOT 4.0B
- APLS 3.3B
- IPO Year
- RIOT N/A
- APLS 2017
- Fundamental
- Price
- RIOT $7.41
- APLS $24.27
- Analyst Decision
- RIOT Strong Buy
- APLS Buy
- Analyst Count
- RIOT 13
- APLS 18
- Target Price
- RIOT $17.42
- APLS $45.53
- AVG Volume (30 Days)
- RIOT 23.9M
- APLS 1.7M
- Earning Date
- RIOT 04-30-2025
- APLS 05-06-2025
- Dividend Yield
- RIOT N/A
- APLS N/A
- EPS Growth
- RIOT N/A
- APLS N/A
- EPS
- RIOT 0.34
- APLS N/A
- Revenue
- RIOT $376,658,000.00
- APLS $781,367,000.00
- Revenue This Year
- RIOT $94.00
- APLS $12.95
- Revenue Next Year
- RIOT $2.60
- APLS $21.35
- P/E Ratio
- RIOT $21.53
- APLS N/A
- Revenue Growth
- RIOT 34.20
- APLS 97.02
- 52 Week Low
- RIOT $6.36
- APLS $23.25
- 52 Week High
- RIOT $15.87
- APLS $59.91
- Technical
- Relative Strength Index (RSI)
- RIOT 37.75
- APLS 40.15
- Support Level
- RIOT $7.50
- APLS $23.25
- Resistance Level
- RIOT $8.83
- APLS $24.88
- Average True Range (ATR)
- RIOT 0.52
- APLS 0.91
- MACD
- RIOT 0.12
- APLS 0.11
- Stochastic Oscillator
- RIOT 10.69
- APLS 38.35
About RIOT Riot Platforms Inc.
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining; Data Center Hosting and Engineering. It generates maximum revenue from the Bitcoin Mining segment which generates revenue from the Bitcoin the company earns through its mining activities.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.